Alzamend Neuro
Date: August 2024 - Present
Alzamend Neuro is a clinical stage biopharmaceutical company, with headquarters in Atlanta, Georgia. Alzamends primary target is Alzheimer’s Disease but is committed to the cures and treatments of Bipolar Disorder, Major Depressive Disorder, and Post-Traumatic Stress Disorder. In October of 2024, they announced that they are partnering with Massachusetts General Hospital for a Phase II clinical trial of their drug candidate, AL001.
Social Media Strategy
.
Graphic Design
.
Copywriting
.
Social Media Strategy . Graphic Design . Copywriting .
Creative Process
In August of 2024 I took over the company's social media strategy to raise general awareness for Alzheimer’s Disease, Bipolar Disorder, Major Depressive Disorder, and Post-Traumatic Stress Disorder. In addition to awareness one of my main goals is to break the stigma against lithium treatments and keep shareholders and the public aware of updates.
